Ocugen, Inc. Common Stock
Here’s whether Ocugen, Inc. Common Stock (OCGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 36 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.91% over 10 days); 3-month momentum negative (-48.1%). Currently 55.6% off its 52-week high. Score: -4/7.
OCGN is trading below its 200-day MA ($1.53) — a key warning sign the longer-term trend is under pressure. An RSI of 36.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +0.8% compares to +22.9% for SPY (trailed the market by 22.0%). The current 55.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.